Tech Company Financing Transactions
HeMemics Biotechnology Funding Round
HeMemics Biotechnology, operating out of Gaithersburg, received $2 million from TEDCO.
Transaction Overview
Company Name
Announced On
5/25/2023
Transaction Type
Venture Equity
Amount
$2,000,000
Round
Seed
Investors
Proceeds Purpose
The company intends to use the funds to accelerate its growth and gain early commercial success.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
708 Quince Orchard Rd. 250A
Gaithersburg, MD 20878
USA
Gaithersburg, MD 20878
USA
Phone
Undisclosed
Website
Email Address
Overview
HeMemics patented preservation solutions, HemSol, are designed to preserve mammalian cells and biologics for short term storage and transportation.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Michael Thomas?
Chief Executive Officer
John Warden
Chief Scientific Officer
David Ho
VP - R & D
Christina Krute
Browse more venture capital transactions:
Prev: 5/25/2023: TRL11 venture capital transaction
Next: 5/25/2023: Tools for Humanity venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to record tech company VC transactions. VC investment data records reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs